News & Updates

Show Multimedia Only

Transforming Obesity Care: Insights from Experts on Semaglutide 2.4 mg

18 Sep 2025

With the launch of semaglutide 2.4 mg (Wegovy) in Singapore, a new chapter in the pharmacological treatment of obesity begins. MIMS Doctor spoke with two leading experts: Professor David Lau, an endocrinologist and Professor Emeritus of Medicine at the University of Calgary Cumming School of Medicine, Canada, and a key contributor to the 2020 Canadian Adult Obesity Guidelines, and Dr Georgia Rigas, Senior Bariatric Medical Practitioner at St George Private Hospital, Sydney, Australia, with extensive experience in primary care obesity management. Both experts shared compelling insights on how semaglutide 2.4 mg is set to transform obesity care across clinical settings.

Transforming Obesity Care: Insights from Experts on Semaglutide 2.4 mg

18 Sep 2025

Expert Consensus on RSV Prevention: Protecting All Infants in Singapore

17 Sep 2025

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children worldwide. [Front Immunol 2022;13:880368] In Singapore, RSV infections significantly contribute to hospital admissions and healthcare utilization in young children, particularly in the first year of life. Severe cases can occur even in healthy infants, placing a considerable strain on families and the healthcare system. [World J Pediatr 2025;21:552-565]

Expert Consensus on RSV Prevention: Protecting All Infants in Singapore

17 Sep 2025

RSV, COVID-19, and pneumococcal disease vaccination updates in Singapore

16 Sep 2025

At the Singapore Thoracic Society (STS) Annual Scientific Meeting 2025, Dr Ian Wee Liang En from the Department of Infectious Diseases/Infection Prevention and Epidemiology, Singapore General Hospital, provided an update on respiratory viral infections and the evolving role of vaccination in reducing disease burden. Dr Wee, who has recently authored several publications on respiratory syncytial virus (RSV), SARS-CoV-2 Omicron, and influenza infections in Singapore, focused his presentation on RSV, with additional updates on COVID-19 and pneumococcal disease.

RSV, COVID-19, and pneumococcal disease vaccination updates in Singapore

16 Sep 2025

What’s hot at APS & MCV 2025?

15 Sep 2025

MIMS Doctor brings you extensive coverage of the Asia Pneumonia Summit & MasterClass in Vaccinology 2025, held recently in Taipei, Taiwan. Check out the latest updates on RSV, pneumococcal disease, new vaccines, plus thought-provoking insights from respiratory experts. [READ THE FULL REPORT]

What’s hot at APS & MCV 2025?

15 Sep 2025

Advancing collaboration in COVID-19 care

16 Aug 2025

Held in June 2025 in Singapore, the Pfizer COVID-CONNECT Masterclass convened international experts to discuss the evolving challenges of COVID-19. Co-chaired by Dr Asok Kurup and Dr Luke Moore, this event assessed the ongoing global impact of the disease and explored evidence-based strategies across the patient journey from early identification to effective treatment.

Advancing collaboration in COVID-19 care

16 Aug 2025

COVID-19 and beyond: Viral infections, preparedness, and long-term impact

15 Aug 2025

At the recent COVID-CONNECT Masterclass, an expert-led session explored where COVID-19 stands among common viral infections today. In a non-promotional symposium supported by Pfizer, infectious disease specialist Dr Leong Hoe Nam, Mount Elizabeth Hospital Novena, Singapore, discussed strategies for managing viral infections and surge preparedness. Complementing this, Professor David Strain from the University of Exeter Medical School, UK highlighted the enduring burden of long COVID.

COVID-19 and beyond: Viral infections, preparedness, and long-term impact

15 Aug 2025

Semaglutide 2.4 mg: Redefining Obesity Care in Singapore

14 Aug 2025

At the landmark launch of semaglutide 2.4 mg (Wegovy) in Singapore, leading experts—including Dr Tham Kwang Wei, Professor David Lau, Professor Walter Abhayaratna, and Dr Georgia Rigas—highlighted the urgent need to treat obesity as a chronic disease. The event saw record participation from over 1,300 healthcare professionals.

Semaglutide 2.4 mg: Redefining Obesity Care in Singapore

14 Aug 2025

Momelotinib simplifies treatment for myelofibrosis with anaemia

22 Jul 2025

At the launch symposium of momelotinib in Singapore, Dr Ruben Mesa, Executive Director of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center and President of Atrium Health Levine Cancer in Winston-Salem, North Carolina, US, shared his insights on the role of momelotinib in the evolving therapy of myelofibrosis. During the case discussion, Dr Than Hein, Senior Consultant at the Singapore General Hospital and Clinical Assistant Professor at Duke-NUS Medical School, also shared his experience with this innovative treatment.

Momelotinib simplifies treatment for myelofibrosis with anaemia

22 Jul 2025

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19

16 Jul 2025

Effective antiviral therapy is crucial for achieving sustained viral clearance and improving outcomes in patients with COVID-19, particularly among immunocompromised individuals.

At the recent ESCMID Global 2025 in Vienna, Austria, Ruth Mokgokong, a pharmacologist at Pfizer, UK, presented findings from the EPIC-IC trial, highlighting the benefits of an extended nirmatrelvir-ritonavir regimen in severely immunocompromised patients with symptomatic COVID-19.

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19

16 Jul 2025

Expert insights on COVID-19: From vaccination to treatment

15 Jul 2025

Even in 2025, COVID-19 remains a significant global health concern. At a Pfizer-sponsored series of integrated symposia held during the ESCMID Global Congress in Vienna, Austria, leading experts presented the latest data and real-world experiences spanning the COVID-19 care continuum—from vaccination strategies to early antiviral treatment.

Expert insights on COVID-19: From vaccination to treatment

15 Jul 2025

News & Updates

Filter by Specialty:

Specialty:

Transforming Obesity Care: Insights from Experts on Semaglutide 2.4 mg

Transforming Obesity Care: Insights from Experts on Semaglutide 2.4 mg

Expert Consensus on RSV Prevention: Protecting All Infants in Singapore

Expert Consensus on RSV Prevention: Protecting All Infants in Singapore

RSV, COVID-19, and pneumococcal disease vaccination updates in Singapore

RSV, COVID-19, and pneumococcal disease vaccination updates in Singapore

What’s hot at APS & MCV 2025?

What’s hot at APS & MCV 2025?

Advancing collaboration in COVID-19 care

Advancing collaboration in COVID-19 care

COVID-19 and beyond: Viral infections, preparedness, and long-term impact

COVID-19 and beyond: Viral infections, preparedness, and long-term impact

Semaglutide 2.4 mg: Redefining Obesity Care in Singapore

Semaglutide 2.4 mg: Redefining Obesity Care in Singapore

Momelotinib simplifies treatment for myelofibrosis with anaemia

Momelotinib simplifies treatment for myelofibrosis with anaemia

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19

Expert insights on COVID-19: From vaccination to treatment

Expert insights on COVID-19: From vaccination to treatment